carbostyril has been researched along with Anterior Horn Cell Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pirmohamed, M | 1 |
Boyce, S; Carlson, E; Hill, RG; Martin, JE; Rupniak, NM; Webb, JK | 1 |
2 other study(ies) available for carbostyril and Anterior Horn Cell Disease
Article | Year |
---|---|
Nucleic acid based therapies: developing frontier for precision medicine.
Topics: Adenoviridae; Aminophenols; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Genetic Therapy; Genomics; Hemophilia A; Humans; Molecular Targeted Therapy; Motor Neuron Disease; Mutation; Nucleic Acids; Oligonucleotides, Antisense; Precision Medicine; Quinolones; United Kingdom | 2018 |
Onset and progression of motor deficits in motor neuron degeneration (mnd) mice are unaltered by the glycine/NMDA receptor antagonist L-701,324 or the MAO-B inhibitor R(-)-deprenyl.
Topics: Animals; Disease Progression; Excitatory Amino Acid Antagonists; Female; Male; Mice; Mice, Mutant Strains; Monoamine Oxidase Inhibitors; Motor Activity; Motor Neuron Disease; Nerve Degeneration; Quinolones; Selegiline; Stereoisomerism | 1999 |